Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM50384861 (CHEMBL2035019) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 246 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Bayer Intellectual Property GmbH US Patent | Assay Description Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragrap... | US Patent US8987273 (2015) BindingDB Entry DOI: 10.7270/Q2CZ35WJ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM50384861 (CHEMBL2035019) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 528 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Curated by ChEMBL | Assay Description Inhibition of AKT1 | J Med Chem 55: 1261-73 (2012) Article DOI: 10.1021/jm201394e BindingDB Entry DOI: 10.7270/Q2H41SGT | |||||||||||
More data for this Ligand-Target Pair |